Metlife Inc (NYSE:MET) saw a downside of -3.06% to close Tuesday at $63.06 after subtracting -$1.99 on the day. The 5-day average trading volume is 3,878,680 shares of the company’s common stock. It has gained $66.98 in the past week and touched a new high 1 time within the past 5 days. An average of 3,763,200 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 3,542,128.
MET’s 1-month performance is 1.04% or $0.65 on its low of $62.33 reached on 08/29/23. The company’s shares have touched a 52-week low of $48.95 and high of $77.36, with the stock’s rally to the 52-week high happening on 01/06/23. YTD, MET has lost -12.86% or -$9.31 and has reached a new high 3 times. However, the current price is down -18.49% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
MET stock investors last saw insider trading activity on Aug 09.DEBEL MARLENE (EVP & Chief Risk Officer) most recently sold 9,391 shares at $63.18 per share on Aug 09. This transaction cost the insider $593,323. EVP, Global Tech. & Ops., PAPPAS BILL, sold 2,857 shares at a price of $70.96 on Mar 02. Then, on Feb 27, EVP, Global Tech. & Ops. PAPPAS BILL sold 11,345 shares at a price of $71.96 per share. This transaction amounted to $816,386.
Valuation Metrics
MET stock has a beta of 1.07. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.67 while the price-to-book (PB) in the most recent quarter is 1.58, with the price to cash flow ratio at 4.65.
As well, the company’s long term debt to equity for the quarter ending June 29 was 0.61, while the total debt to equity was 0.61. The firm’s gross profit as reported stood at $2.86 billion against revenue of $69.9 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 72.16% to $370.0 million, while revenue of $14.0 million was 96.22% off the previous quarter. Analysts expected MET to announce $1.87 per share in earnings in its latest quarter, but it posted $1.94, representing a 3.70% surprise. EBITDA for the quarter stood at more than $430.0 million. Shareholders hold equity totaling $752.02 million.
Let’s look briefly at Metlife Inc (MET) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 26 September was 38.77% to suggest the stock is trending Neutral, with historical volatility in this time period at 27.69%.
The stock’s 5-day moving average is $64.66, reflecting a -4.97% or -$3.30 change from its current price. MET is currently trading +0.85% above its 20-day SMA, +7.41% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +6.88% and SMA200 by-15.46%.
Stochastic %K and %D was 37.43% and 48.09% and the average true range (ATR) pointed at 1.22. The RSI (14) points at 45.26%, while the 14-day stochastic is at 12.50% with the period’s ATR at 1.19. The stock’s 9-day MACD Oscillator is pointing at -1.11 and -0.45 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Metlife Inc (NYSE: MET), Jefferies upgraded it to a Buy rating. They previously had a Hold rating on the stock. Analysts offering their rating for MET stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate MET as a “sell,”, while 5 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 13 have offered a “buy” rating.
What is MET’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $69.00 and a high of $85.00, with their median price target at $79.50. Looking at these predictions, the average price target given by analysts is for Metlife Inc (MET) stock is $77.96.
